Workflow
Dole(DOLE) - 2025 Q1 - Earnings Call Transcript
2025-05-12 13:00
Dole (DOLE) Q1 2025 Earnings Call May 12, 2025 08:00 AM ET Speaker0 Welcome to Dole plc's First Quarter twenty twenty five Earnings Conference Call and Webcast. Today's conference is being broadcast live over the Internet and is also being recorded for playback purposes. Currently, all participants are in a listen only mode. After the speakers' presentation, there will be a question and answer session. For opening remarks and introductions, I would like to turn the call over to the Head of Investor Relation ...
Joint Stock Company Kaspi.kz(KSPI) - 2025 Q1 - Earnings Call Transcript
2025-05-12 13:00
Kaspi.kz (KSPI) Q1 2025 Earnings Call May 12, 2025 08:00 AM ET Speaker0 Hello, and welcome, everyone, to the Kaspi KZ First Quarter twenty twenty five Financial Results. I will now hand you over to David Ferguson, Head of Investor Relations at Cassidy Cape Verde to begin. David, please go ahead. Speaker1 Great. Thank you, Maxine. Good afternoon, good morning to everyone. Thanks a lot for joining us for our first quarter twenty twenty five financial results. I'm David Ferguson. I'm joined, as usual, by Mikha ...
Harvard Bioscience(HBIO) - 2025 Q1 - Earnings Call Transcript
2025-05-12 13:00
Financial Data and Key Metrics Changes - Revenue for Q1 2025 was $21.8 million, down from $24.5 million in Q1 2024, aligning with the higher end of guidance [7][10] - Gross margin decreased to 56% from 60.3% in the previous year [8][14] - Operating loss was $49.7 million compared to a loss of $2.3 million in Q1 2024, primarily due to a goodwill impairment charge of $48 million [8][10] - Adjusted EBITDA was $800,000, down from $1.6 million in Q1 2024 [15] - Cash flow from operations improved to $3 million from $1.4 million in the prior year [16] Business Line Data and Key Metrics Changes - Revenue in The Americas declined 9.4% year-over-year and 5.4% sequentially [11] - European revenue decreased 29% sequentially and 9% year-over-year [12] - APAC revenue increased 6.6% sequentially but was down 17% compared to the prior year [13] Market Data and Key Metrics Changes - The Americas faced a slowdown attributed to budget clarity issues for academic and NIH funding [11] - European sales were impacted by a lack of seasonal bump and lower CRO sales [12] - APAC market showed slight sequential growth but anticipated challenges due to tariff announcements [13] Company Strategy and Development Direction - Focus on expanding adoption of new products while reducing costs, with an expected reduction in operating expenses by an additional $1 million per quarter starting Q2 2025 [25] - New product introductions include the SOHO telemetry devices and VivaMARS system, targeting both academic and industrial customers [19][20] - Emphasis on bioproduction applications and exploring partnerships for CAR T therapy production [21][31] Management's Comments on Operating Environment and Future Outlook - Management expressed concerns over NIH funding and the impact of tariffs on revenue, particularly in China [25][53] - Positive outlook on the adoption of organoid systems due to government policy changes encouraging alternative testing methods [24][34] - Anticipated Q2 revenue guidance is between $18 million to $20 million, with gross margin expected to be in the 55% to 57% range [25] Other Important Information - Goodwill impairment charge of $48 million was recorded due to a decrease in market capitalization [10][29] - Net debt decreased to $30.8 million, reflecting improved cash flow management [16] Q&A Session Summary Question: Can you elaborate on the impairment charge? - Management explained that the impairment was due to a drop in market cap, necessitating a reassessment of goodwill, leading to a non-cash charge of $48 million [29] Question: What about the bioproduction business and CAR T therapy? - Management confirmed that the BTX system is being adopted by a domestic biotech for CAR T therapy production, indicating strong traction in the market [31] Question: How is the MEA product line performing amid NIH funding uncertainties? - Management noted strong interest in the MEA product line, particularly from academic researchers, despite a slowdown in purchasing processes due to NIH staffing changes [34][45] Question: What are the refinancing plans? - Management indicated that refinancing will be more expensive than commercial rates, with terms likely spanning four to five years [46][48]
Eve (EVEX) - 2025 Q1 - Earnings Call Transcript
2025-05-12 13:00
Financial Data and Key Metrics Changes - The company reported a net loss of $49 million in Q1 2025, with R&D expenses at $44 million and SG&A expenses at nearly $8 million [21][20] - Cash flow from operations consumed $25 million, which is lower than previous quarters due to a temporary working capital gain [21][22] - The company ended Q1 2025 with $288 million in cash, down $15 million from the end of 2024, but total liquidity was $411 million [22] Business Line Data and Key Metrics Changes - The company invested $45 million in program development during the first quarter, focusing on eVTOL, service and support solutions, and urban air traffic management software [20] - The total preorder backlog remains at approximately 2,800 aircraft, valued at around $14 billion, with contracts secured for aftermarket services potentially generating $1.6 billion in revenue [18][19] Market Data and Key Metrics Changes - The company has secured contracts with 14 different customers for its EVE TechCare suite, covering around 1,100 aircraft, which is about 40% of the preorder backlog [19] - The order book includes customers from various sectors, including air mainliners, regional airliners, helicopter operators, ride-sharing platforms, and leasing companies [18] Company Strategy and Development Direction - The company is focused on developing its eVTOL technology and has reached significant milestones, including ground tests and preparations for initial flights [5][6] - The assembly line for the conforming prototypes is set up at Embraer's facility, with plans to start assembly in the second half of 2025 [16][17] - The company aims to create a comprehensive ecosystem for urban air mobility, engaging with partners in infrastructure and energy [19] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in meeting ambitious targets for prototype assembly and certification campaigns, with initial flights expected in 2026 [20][22] - The company is focused on maintaining a solid cash position and is comfortable with its financial guidance for the year [21][22] Other Important Information - The company is actively engaged with suppliers, with a noticeable increase in activity related to the production of parts for the conforming prototypes [15] - The IronBird simulator is being used to integrate and troubleshoot various systems, which is crucial for the certification campaign [12][13] Q&A Session Summary Question: R&D spending expectations - Management indicated that R&D spending is expected to remain around $44 million per quarter for the rest of the year [26][27] Question: Certification aircraft build timeline - The conforming prototype is on schedule, with the facility ready to receive tooling for assembly [29][30] Question: Services contract backlog details - The $1.6 billion backlog includes battery replacements and repairs but does not account for future upgrades [34][35] Question: Order book and customer engagement - The order book remains stable, with ongoing customer engagement and a focus on developing the first operational city [40][41] Question: Cash consumption guidance - Cash consumption is expected to be closer to the lower end of the $200 million to $250 million range for the year [43][44] Question: Prototypes and cash consumption - Most cash is allocated to R&D, with the focus on development rather than immediate prototype costs [51][52] Question: Service and maintenance business segment - The company is preparing for seamless operation and support for the first aircraft, with training solutions already in development [55][56] Question: Software progress for services - The software side is actively being developed to ensure user-friendliness and operational efficiency [62] Question: Future financing options - The company has multiple funding options available, ensuring sufficient liquidity for upcoming years [65][66]
EnviroStar(EVI) - 2025 Q3 - Earnings Call Transcript
2025-05-12 01:02
EVI Industries (EVI) Q3 2025 Earnings Call May 11, 2025 08:00 PM ET Company Participants Henry Nahmad - Chairman, CEO & President Henry Nahmad Hello, and welcome to EVI Industries Earnings Call for the Third Quarter of the Fiscal Year Ended 06/30/2025. I am Henry Nahmad, Chairman and CEO of EVI. Before we proceed, we would like to discuss our cautionary statement. This earnings call contains forward looking statements as defined by SEC rules and regulations. Forward looking statements are subject to a numbe ...
EnviroStar(EVI) - 2025 Q3 - Earnings Call Transcript
2025-05-12 01:02
EVI Industries (EVI) Q3 2025 Earnings Call May 11, 2025 08:00 PM ET Company Participants Henry Nahmad - Chairman, CEO & President Henry Nahmad Hello, and welcome to EVI Industries Earnings Call for the Third Quarter of the Fiscal Year Ended 06/30/2025. I am Henry Nahmad, Chairman and CEO of EVI. Before we proceed, we would like to discuss our cautionary statement. This earnings call contains forward looking statements as defined by SEC rules and regulations. Forward looking statements are subject to a numbe ...
EnviroStar(EVI) - 2025 Q3 - Earnings Call Transcript
2025-05-12 01:00
EVI Industries (EVI) Q3 2025 Earnings Call May 11, 2025 08:00 PM ET Speaker0 Hello, and welcome to EVI Industries Earnings Call for the Third Quarter of the Fiscal Year Ended 06/30/2025. I am Henry Nahmad, Chairman and CEO of EVI. Before we proceed, we would like to discuss our cautionary statement. This earnings call contains forward looking statements as defined by SEC rules and regulations. Forward looking statements are subject to a number of risks and uncertainties, including those set forth in our ear ...
Contextlogic Inc.(LOGC) - 2025 Q1 - Earnings Call Transcript
2025-05-09 22:02
ContextLogic (LOGC) Q1 2025 Earnings Call May 09, 2025 05:00 PM ET Company Participants Rishi Bajaj - CEO & Director Operator Good afternoon, ladies and gentlemen, and thank you for standing by. Welcome to ContextLogic's First Quarter twenty twenty five Earnings Conference Call. At this time, participants are in a listen only mode and there will not be a question and answer session at the conclusion of today's call. However, a recording and transcript will be made available online and management will make t ...
Contextlogic Inc.(LOGC) - 2025 Q1 - Earnings Call Transcript
2025-05-09 22:02
ContextLogic (LOGC) Q1 2025 Earnings Call May 09, 2025 05:00 PM ET Company Participants Rishi Bajaj - CEO & Director Operator Good afternoon, ladies and gentlemen, and thank you for standing by. Welcome to ContextLogic's First Quarter twenty twenty five Earnings Conference Call. At this time, participants are in a listen only mode and there will not be a question and answer session at the conclusion of today's call. However, a recording and transcript will be made available online and management will make t ...
Motorsport Games(MSGM) - 2025 Q1 - Earnings Call Transcript
2025-05-09 22:02
Motorsport Games (MSGM) Q1 2025 Earnings Call May 09, 2025 05:00 PM ET Company Participants Ben Rossiter-Turner - VP of CompetitionStephen Hood - CEO & PresidentStanley Beckley - Chief Financial Officer Operator Thank you for standing by, and welcome to Motorsport Games Incorporated First Quarter twenty twenty five Earnings Call. All lines have been placed on mute to prevent any background noise. As a reminder, today's conference is being recorded. I would like to turn the conference over to Ben Rossiter Tu ...